| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $4.7M | $919.0K | $193.3K |
| YoY Revenue Growth % | +407.6% | +375.3% | — |
| Gross Profit | $2.8M | $300.0K | — |
| Gross Margin % | 59.6% | 32.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.1M | -$4.6M | -$5.5M |
| Operating Margin % | -45.9% | -80.0% | -80.0% |
| Net Income (GAAP) | -$3.0M | -$4.6M | -$5.4M |
| EBITDA (Normalized) | -$2.0M | -$4.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.1M | -$3.5M | -$3.6M |
| Capital Expenditures (CapEx) | $161.0K | $322.0K | — |
| Free Cash Flow (FCF) | -$1.3M | -$3.8M | -$3.6M |
| FCF Margin % | -28.1% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $38.6M | $3.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $40.8M | -$1.0M | — |